Molecular Fluorescent Imaging of Metastatic Tumors with Conditionally Replication-Selective Adenovirus and GFP Gene
使用条件复制选择性腺病毒和 GFP 基因对转移性肿瘤进行分子荧光成像
基本信息
- 批准号:15591475
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Currently available methods for detection of tumors in vivo such as X-ray, computed tomography, and ultrasonography are noninvasive and well studied ; the images, however, are not specific for tumors. Direct optical imaging of tumor cells in vivo that can clearly distinguish them from surrounding normal tissues may be clinically useful. Here, we describe a new approach to visualizing tumors whose fluorescence can be detected using tumor-specific replication-competent adenovirus (OBP-301, "Telomelysin") in combination with replication-deficient adenovirus expressing GFP (Ad-GFP). Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of telomerase, which is highly active in cancer cells, but is quiescent in most normal somatic cells. We constructed an adenovirus 5 vector, in which the hTERT promoter element drives expression of E1A and E1B genes linked with an IRES, and showed that OBP-301 replicated efficiently exclusively in human cancer cells, but not in normal cells … More such as human fibroblasts. When the human lung and colon cancer cell lines H1299 and SW620 were infected with Ad-GFP at low multiplicity of infection(MOI), GFP expression could not be detected under a fluorescence microscope ; in the presence of OBP-301, however, Ad-GFP replicated in these tumor cells and showed strong green signals. In contrast, co-infection of OBP-301 and Ad-GFP did not show any signals in normal cells such as WI-38 fibroblasts. We also found that established subcutaneous tumors could be visualized following intratumoral injection of OBP-301 and Ad-GFP. A549 human lung tumors and SW620 human colon tumors transplanted into BALB/c nu/nu mice were intratumorally injected with 8 x 10^5 plaque forming units(PFU) of Ad-GFP in combination with 8 x 10^6 PFU of OBP-301. Within 3 days of treatment, the fluorescence of the expressed GFP became visible by 3CCD camera in these tumors, whereas intratumoral injection of Ad-GFP alone could not induce GFP fluorescence. Moreover, intrathoracic administration of Ad-GFP and OBP-301 could visualize disseminated A549 tumor nodules in mice following intrathoracic implantation. Our results indicate that intratumoral or intrathoracic injection of Ad-GFP in combination with OBP-301 might be a useful diagnostic method that provides a foundation for future clinical application. Less
目前可用于检测体内肿瘤的方法,如X射线,计算机断层扫描和超声检查是非侵入性的,并进行了充分的研究;然而,图像并不特异于肿瘤。直接光学成像的肿瘤细胞在体内,可以清楚地区分他们从周围的正常组织可能是临床上有用的。在这里,我们描述了一种新的方法来可视化肿瘤,其荧光可以检测使用肿瘤特异性复制能力腺病毒(OBP-301,“端粒溶素”)与表达GFP的复制缺陷型腺病毒(Ad-GFP)的组合。人端粒酶逆转录酶(Human telomerase reverse transcriptase,hTERT)是端粒酶的催化亚单位,在癌细胞中高度活跃,而在正常体细胞中处于静止状态。我们构建了腺病毒5载体,其中hTERT启动子元件驱动与IRES连接的E1 A和E1 B基因的表达,并显示OBP-301仅在人癌细胞中有效复制,而在正常细胞中不复制 ...更多信息 如人成纤维细胞。当用Ad-GFP以低感染复数(MOI)感染人肺癌和结肠癌细胞系H1299和SW 620时,在荧光显微镜下不能检测到GFP表达;然而,在存在OBP-301的情况下,Ad-GFP在这些肿瘤细胞中复制并显示出强的绿色信号。相反,OBP-301和Ad-GFP的共感染在正常细胞如WI-38成纤维细胞中没有显示任何信号。我们还发现,在瘤内注射OBP-301和Ad-GFP后,可以观察到已建立的皮下肿瘤。向移植到BALB/c nu/nu小鼠中的A549人肺肿瘤和SW 620人结肠肿瘤瘤内注射8 × 10^5空斑形成单位(PFU)的Ad-GFP和8 × 10^6 PFU的OBP-301。在治疗的3天内,表达的GFP的荧光在这些肿瘤中通过3CCD照相机变得可见,而单独的Ad-GFP瘤内注射不能诱导GFP荧光。此外,胸腔内施用Ad-GFP和OBP-301可以使胸腔内植入后小鼠中的播散性A549肿瘤结节可视化。我们的研究结果表明,Ad-GFP联合OBP-301瘤内或胸腔内注射可能是一种有用的诊断方法,为未来的临床应用提供了基础。少
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ohatani, S., Fujiwara, T.et al.: "Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo"Molecular Cancer Therapeutics. 3. 93-100 (2004)
Ohatani, S., Fujiwara, T.等人:“体内腺病毒 p53 瘤内给药后 p53 靶向基因表达的定量分析和 p53 转录活性的可视化”《分子癌症治疗》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Telomerase-specific replication-selective virotherapy for human cancer
- DOI:10.1158/1078-0432.ccr-1075-3
- 发表时间:2004-01-01
- 期刊:
- 影响因子:11.5
- 作者:Kawashima, T;Kagawa, S;Fujiwara, T
- 通讯作者:Fujiwara, T
Kawashima, T., Fujiwara, T.et al.: "Telomerase-specific repiication-selective virotherapy for human cancer"Clinical Cancer Research. 10. 285-292 (2004)
Kawashima, T.、Fujiwara, T.等人:“人类癌症的端粒酶特异性复制选择性病毒疗法”临床癌症研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
转导野生型 p53 基因的骨髓源性树突状细胞瘤内给药的抗肿瘤作用。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Murakami T;Fujiwara T;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJIWARA Toshiyoshi其他文献
FUJIWARA Toshiyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJIWARA Toshiyoshi', 18)}}的其他基金
Development of the Dual fluorescent cytology with tumor-specific viruses for gastrointestinal cancer precision medicine
开发肿瘤特异性病毒双荧光细胞学用于胃肠道癌症精准医疗
- 批准号:
16H05416 - 财政年份:2016
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Fluorescent virus-guided capturing of epithelial-mesenchymal transition (EMT)-induced circulating tumor cells (CTCs) for genetic analysis
荧光病毒引导捕获上皮间质转化 (EMT) 诱导的循环肿瘤细胞 (CTC) 用于遗传分析
- 批准号:
25670580 - 财政年份:2013
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
"Cell-in-cell" activity-based tumor-specific delivery of biologics
基于“细胞内细胞”活性的肿瘤特异性生物制剂递送
- 批准号:
25293283 - 财政年份:2013
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular therapy for gastric cancer using HER2-extracellular domain-expressing adenovirus
使用表达 HER2 胞外结构域的腺病毒进行胃癌分子治疗
- 批准号:
22390256 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Telomerase-specific virotherapy for malignant mesothelioma
端粒酶特异性病毒疗法治疗恶性间皮瘤
- 批准号:
19390365 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Telomerase-specific fluorescent navigation system for lung cancer surgery
用于肺癌手术的端粒酶特异性荧光导航系统
- 批准号:
17390381 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Analysis of Resistance to p53 Gene Therapy in Human Lung Cancer
人类肺癌 p53 基因治疗耐药性的分子分析
- 批准号:
13671390 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Gene Therapy for Lung Cancer using a Novel Antiangiogenic Factor BAI1
使用新型抗血管生成因子 BAI1 开发肺癌基因疗法
- 批准号:
11671325 - 财政年份:1999
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Advancing Systematic Delivery of Oncolytic Adenovirus for Pancreatic Cancer
推进溶瘤腺病毒治疗胰腺癌的系统递送
- 批准号:
10734709 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster
开发针对特定细胞表面标记物的抗体,以评估叙利亚仓鼠腺病毒 14 和 14p1 感染期间的巨噬细胞极化
- 批准号:
10725702 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Development of novel immunotherapy with stem cells loaded oncolytic adenovirus for advanced cancers
开发携带溶瘤腺病毒的干细胞治疗晚期癌症的新型免疫疗法
- 批准号:
23K19510 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
INVECTA: Integrative characterisation of Novel adenovirus VECtors aimed at Therapeutic Applications
INVECTA:针对治疗应用的新型腺病毒载体的综合表征
- 批准号:
EP/Y036883/1 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Research Grant
iAds: Intelligent Design Of Adenovirus Vectors
iAds:腺病毒载体的智能设计
- 批准号:
10079200 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
EU-Funded
Development of recombinant adenovirus medicines
重组腺病毒药物的开发
- 批准号:
23H00552 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Mechanistic factors limiting utility of adenovirus vectors for treatment of neopla
限制腺病毒载体治疗肿瘤的机制因素
- 批准号:
10618174 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Advanced Oncolytic Adenovirus Enabling Systemic Therapy of PDAC
先进的溶瘤腺病毒实现 PDAC 的系统治疗
- 批准号:
10566530 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Epigenetic Regulation of the Adenovirus Genome
腺病毒基因组的表观遗传调控
- 批准号:
468931 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Operating Grants
Investigating a Novel Example of Adenovirus Viral Mimicry and Its Effect on Transcription
研究腺病毒病毒拟态的新例子及其对转录的影响
- 批准号:
570188-2022 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral